With the present study, we aimed to evaluate the lack of benefit of temozolomide for MGMT methylated patients with high vascular glioblastomas, since previous results published in [47] concluded that the combined effect of MGMT methylation and moderate vascularity of the tumor causes a benefit in glioblastoma patient overall survival. This evidence concerns the gene MGMT and glioblastoma.